Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 27, 2022, titled "Tergene Biotech Pvt. Ltd., a Joint Venture company, receives SEC recommendation for pneumococcal 15 valent (PCV15) vaccine.".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 27, 2022, titled "Tergene Biotech Pvt. Ltd., a Joint Venture company, receives SEC recommendation for pneumococcal 15 valent (PCV15) vaccine.".